Search

everythinglearnresearchcommunity

for

Search:↓

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

AA-PRP injections significantly promote hair growth but need better study design for clear efficacy.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Men who start puberty later may have lower sperm quality and different hormone levels in adulthood.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Tinea capitis in older adults is often misdiagnosed but can be effectively treated with antifungal therapy.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Trichoscopy is a valuable tool for accurately diagnosing scalp conditions without invasive procedures.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

The 2940-nm Er: YAG laser combined with medication is a safe and better treatment for male hair loss than medication alone.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Various techniques and tools for hair restoration were presented in 1998, including a mathematical model for donor area, use of lasers in surgery, methods for controlling grafted hair direction, and ways to increase graft yield. Satisfaction rates were around 39%, and studies showed trauma and dehydration can damage hair follicles.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib is an effective and safe treatment for alopecia areata.

UV exposure reduced hair shine in mice, but minoxidil helped restore it.